Polymorphism within the tumor necrosis factor α (TNF) promoter region in patients with ankylosing spondylitis

被引:43
|
作者
Kaijzel, EL [1 ]
Brinkman, BMN [1 ]
van Krugten, MV [1 ]
Smith, L [1 ]
Huizinga, TWJ [1 ]
Verjans, GMGM [1 ]
Breedveld, FC [1 ]
Verweij, CL [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands
关键词
tumor necrosis factor alpha; gene polymorphism; ankylosing spondylitis; HLA-B27;
D O I
10.1016/S0198-8859(98)00099-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to HLA-B27, other genetic factors are thought to be involved in the pathogenesis of ankylosing spondylitis (AS). Because of the location of the TNF gene in the vicinity of the HLA-B locus, and the prominent role in inflammation of its produce, we investigated the association between BS and two G to A transition polymorphisms located at position -238 and -376 in the promoter region of the TNF gene. The distribution of the TNF alleles was determined in 86 HLA-B27+ AS patients and 163 healthy controls. From the 86 AS patients, 33 suffered from acute anterior uveitis (AAU). No significant difference for the TNF-376 polymorphism in AS and healthy controls was observed. The frequency of the TNF-238A allele in HLA-B27(+) AS patients was significantly decreased compared to random controls (p = 0.021). However, the frequency of the TNF-238A allele in HLA-B27(+) AS patients was not significantly different from chat observed in HLA-B27(+) healthy individuals (p = 0.6). Assessment of association showed that the TNF-238G allele is in linkage disequilibrium with the HLA-B27 allele (Delta = 0.051; P = 0.008). Therefore, we conclude that the association between TNF-238G and AS is secondary to the HLA-B27 gene and that TNF-238 and TNF-376 alleles are nor likely to be involved in the susceptibility to AS. Human Immunology 60, 140-144 (1999). (C) American Society for Histocompatibility and Immunogenetics, 1999. Published by Elsevier Science Inc.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 50 条
  • [41] An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis
    Osman, Mohammed S.
    Maksymowych, Walter P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (02) : 125 - 131
  • [42] Tumour necrosis factor inhibitors in ankylosing spondylitis
    Reed, M. R.
    Taylor, A. L.
    INTERNAL MEDICINE JOURNAL, 2008, 38 (10) : 781 - 789
  • [43] Drug Insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis
    Henderson, C
    Davis, JC
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (04): : 211 - 218
  • [44] The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis
    Elkayam, O
    Caspi, D
    Reitblatt, T
    Charboneau, D
    Rubins, JB
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (04) : 283 - 288
  • [45] Incidence of Tuberculosis Among Korean Patients with Ankylosing Spondylitis Who Are Taking Tumor Necrosis Factor Blockers
    Kim, Eun-Mi
    Uhm, Wan-Sik
    Bae, Sang-Cheol
    Yoo, Dae-Hyun
    Kim, Tae-Hwan
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (10) : 2218 - 2223
  • [46] Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
    Konsta, Maria
    Nurmohamed, Michael T.
    Iliopoulos, Alexios
    Sfikakis, Petros P.
    van Denderen, J. Christiaan
    Visman, Ingrid
    Sakelariou, Grigorios T.
    van der Horst-Bruinsma, Irene E.
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (03) : 342 - 350
  • [47] Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis
    Kwon, Inbeom
    Choi, Nayeon
    Shin, Ji Hui
    Lee, Seunghun
    Nam, Bora
    Kim, Tae-Hwan
    JOURNAL OF RHEUMATIC DISEASES, 2024, 31 (01): : 41 - 48
  • [48] Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis
    Bon San Koo
    Yu-Cheol Lim
    Min-Young Lee
    Ja-Young Jeon
    Hyun-Jeong Yoo
    In-Sun Oh
    Ju-Young Shin
    Tae-Hwan Kim
    Rheumatology and Therapy, 2021, 8 : 347 - 359
  • [49] Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis
    Koo, Bon San
    Lim, Yu-Cheol
    Lee, Min-Young
    Jeon, Ja-Young
    Yoo, Hyun-Jeong
    Oh, In-Sun
    Shin, Ju-Young
    Kim, Tae-Hwan
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 347 - 359
  • [50] Comparison of Incidence or Recurrence of Anterior Uveitis in Patients with Ankylosing Spondylitis Treated with Tumor Necrosis Factor Inhibitors
    Kwon, Hyeon Yoon
    Kim, Yu Jeong
    Kim, Tae-Hwan
    Ahn, Seong Joon
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)